Filing Flows › Prokidney (PROK) › Q4 2025
Prokidney (PROK) Q4 2025 earnings results (fourth quarter 2025)
10-K filed Mar 18, 2026
Prokidney (PROK) reported revenue of $225K for the fourth quarter 2025 (Q4 2025), +196% from a year earlier and +4% from the quarter before.
Prokidney, Q4 2025: revenue $225K (+196% year over year), net loss $40.9M, operating cash flow −$32.5M. The chart follows the revenue to costs, profit and cash.
| Q4 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $225K | +4% | +196% |
| Operating profit | −$45.4M | — | — |
| Net earnings | −$40.9M | — | — |
| Operating cash flow | −$32.5M | — | — |
What changed
Revenue was $225K in Q4 2025, up 196% year over year and up 4% from the previous quarter.
Operating costs exceeded revenue by $45.4M, an operating margin of -20164.9%. Total costs fell 12% while revenue rose 196%. The quarter ended with a net loss of $40.9M, wider than the previous quarter's $35.8M loss. Minority interests bore $21.6M of it: to shareholders the quarter was a loss of $19.2M.
Operating cash flow was −$32.5M. Non-cash charges added back $1.8M of depreciation and amortization and $5.7M of share-based compensation. Capital expenditures of $5.8M exceeded it, leaving free cash flow of −$38.3M.
Questions
What was Prokidney's revenue in the fourth quarter 2025?
Prokidney (PROK) reported revenue of $225K for the fourth quarter 2025 (Q4 2025), +196% from a year earlier and +4% from the quarter before.
Source: Prokidney 10-K on SEC EDGAR.